The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH ...
Clinical Trials Arena on MSN
The clinical trial supply model of the future
With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.
Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...
In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more ...
Scientific advancements have helped millions of people living with cancer, heart disease, arthritis, obesity, and other diseases. Essential for the development of new therapies are the thousands of ...
Can you leave a clinical trial early? Learn your rights, what happens if you withdraw, and how to exit safely without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results